Grooten J, Leroux-Roels G, Fiers W
Eur J Immunol. 1987 May;17(5):605-11. doi: 10.1002/eji.1830170505.
In vivo, subclones derived from EL4 lymphoma cells generate suppressor T lymphocytes specific for anti-EL4 immune responses. Spleen cells of EL4-sensitized C57BL/6 mice down-regulate the in vitro induction of EL4-specific cytolytic T lymphocytes (CTL). In addition, EL4-sensitized spleen cells interfere with the antigen response of two T lymphocyte clones. These recognize, in an H-2b context, a self-antigen on spleen cells that is also expressed by transformed cells, including EL4. The simultaneous anti-self and anti-EL4 specificity of the helper and suppressor activities suggests, therefore, that they are the product of an in vivo autoimmune reaction to EL4. The anti-self suppression might aim to re-establish self-tolerance, at the same time down-regulating responses against immunogenic epitopes that are co-expressed with the self-antigen on the EL4 cells. This agrees well with our observation that suppressor T cells, apparently elicited by suppressogenic epitopes on non-immunogenic EL4 subclones, down-regulate the CTL response elicited by immunogenic EL4 subclones. The additional self-specificity of this suppression indicates that the suppressogenic epitopes at least in part represent EL4 self-antigens.
在体内,源自EL4淋巴瘤细胞的亚克隆产生针对抗EL4免疫反应的抑制性T淋巴细胞。EL4致敏的C57BL/6小鼠的脾细胞下调EL4特异性细胞毒性T淋巴细胞(CTL)的体外诱导。此外,EL4致敏的脾细胞干扰两个T淋巴细胞克隆的抗原反应。在H-2b背景下,它们识别脾细胞上的一种自身抗原,该抗原也由包括EL4在内的转化细胞表达。因此,辅助和抑制活性同时具有抗自身和抗EL4特异性,表明它们是对EL4的体内自身免疫反应的产物。抗自身抑制可能旨在重新建立自身耐受性,同时下调针对与EL4细胞上自身抗原共表达的免疫原性表位的反应。这与我们的观察结果非常吻合,即显然由非免疫原性EL4亚克隆上的抑制性表位引发的抑制性T细胞下调了由免疫原性EL4亚克隆引发的CTL反应。这种抑制的额外自身特异性表明,抑制性表位至少部分代表EL4自身抗原。